Quarter Period Statement Of Income

Oncolys BioPharma Inc. - Filing #7609193

Concept 2022-01-01 to
2022-03-31
2021-01-01 to
2021-03-31
Quarter period statement of income
Statement of income
Net sales
193,125,000 JPY
62,603,000 JPY
Cost of sales
65,641,000 JPY
35,427,000 JPY
Gross profit (loss)
127,483,000 JPY
27,175,000 JPY
Selling, general and administrative expenses
512,231,000 JPY
376,629,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
-384,747,000 JPY
-349,453,000 JPY
Non-operating income
Interest income
153,000 JPY
131,000 JPY
Non-operating income
39,533,000 JPY
26,516,000 JPY
Non-operating expenses
Interest expenses
864,000 JPY
932,000 JPY
Non-operating expenses
4,415,000 JPY
26,689,000 JPY
Ordinary profit (loss)
-349,628,000 JPY
-349,626,000 JPY
Extraordinary income
Extraordinary income
21,406,000 JPY
JPY
Profit (loss) before income taxes
-328,222,000 JPY
-349,626,000 JPY
Income taxes - current
738,000 JPY
941,000 JPY
Income taxes
738,000 JPY
941,000 JPY
Profit (loss)
-328,960,000 JPY
-350,567,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.